Oxazepam antibody

Catalog No. ABIN1001448

This anti-Oxazepam antibody is a Sheep Polyclonal antibody detecting Oxazepam in ELISA, IA and AP. Suitable for Various Species.

Quick Overview for Oxazepam antibody (ABIN1001448)

Target: Oxazepam

Reactivity: Various Species

Host: Sheep

Clonality: Polyclonal

Conjugate: This Oxazepam antibody is un-conjugated

Application: ELISA, Immunoassay (IA), Affinity Purification (AP)

Product Details anti-Oxazepam Antibody

Purpose: Oxazepam

Specificity: ELISA microtitre plate based and expressed as % crossreactivity*. The antibody exhibited crossreactivity for the following compounds: Lorazepam < 5.1 % ,Nitrazepam 187.9 %,Flunitrazepam < 5.1 %,7-Aminoflunitrazepam < 5.1 %,Clobazam < 5.1 %,Clonazepam 8.9 %,7-Aminoclonazepam < 5.1 %,Diazepam < 5.1 %,Nordiazepam 229.0 %, Temazepam < 5.1 %,Alprazolam < 5.1 %,Triazolam< 5.1 %,Bromazepam 29.0 %,Prazepam < 5.1 %, * crossreactivity profile may vary with tracer used.

Purification: Salt fractionation.

Immunogen: Oxazepam-BSA/KLH

Isotype: IgG

Application Details

Application Notes:

Application_Dilutions: 2.5 μg/mL

Tested_Applications: The antibody is suitable for the development of immunoassays or immunoaffinity purification columns.

Comment:

10 ng/mL Oxazepam produces 93 % inhibition in a competitive ELISA employing Oxazepam polyclonal antibody.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: 20 mM Phosphate, 150 mM Sodium Chloride. pH 7.4, 0.09 % Sodium Azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Can be stored for up to 3 months at +2°C - +8°C. For long term storage, aliquot and store at ≤-20 °C. Avoid repeated freeze/thaw cycles. Product should be protected from light exposure.

Target Details for Oxazepam

Target: Oxazepam

Target Type: Chemical

Background: The benzodiazepines are a group of over 20 structurally related central nervous system depressant drugs, each group varying considerably in their potency and clinical effects.